August 20, 2012
A former manager at Array BioPharma Inc., a Colorado-based developer of cancer drugs, agreed Monday to settle allegations brought by the U.S. Securities and Exchange Commission that he illegally traded on insider information about a pending partnership agreement with Swiss drugmaker Novartis AG.